Concepedia

Antonio Lucena-Cacace

AL

Statistics

Publications

17

Citations

804

H-Index

15

Active since

2013

Affiliations

Instituto de Biomedicina de Sevilla(Current)

Hospital Universitario Virgen del Rocío

Universidad de Sevilla

Consejo Superior de Investigaciones Científicas

Kyoto University

Antonio Lucena-Cacace is an author at Instituto de Biomedicina de Sevilla specializing in medicine, molecular oncology, and cancer stem cells.

ORCID

Publications per year

2013–2022

17

Publications

17

<i>NAMPT</i> Is a Potent Oncogene in Colon Cancer Progression that Modulates Cancer Stem Cell Properties and Resistance to Therapy through Sirt1 and PARP

Antonio Lucena-Cacace, Daniel Otero-Albiol, Manuel P. Jiménez-García et al. · Clinical Cancer Research · 2017 · 160 citations · Full text

, , +17

NAMPT overexpression induces cancer stemness and defines a novel tumor signature for glioma prognosis

Antonio Lucena-Cacace, Daniel Otero-Albiol, Manuel P. Jiménez-García et al. · Oncotarget · 2017 · 86 citations · Full text

, , +17

The Cargo Protein MAP17 (PDZK1IP1) Regulates the Cancer Stem Cell Pool Activating the Notch Pathway by Abducting NUMB

José Manuel García-Heredia, Antonio Lucena-Cacace, Eva M. Verdugo‐Sivianes et al. · Clinical Cancer Research · 2017 · 81 citations · Full text

, , +17

ERRγ enhances cardiac maturation with T-tubule formation in human iPSC-derived cardiomyocytes

Kenji Miki, Kohei Deguchi, Misato Nakanishi-Koakutsu et al. · Nature Communications · 2021 · 73 citations · Full text

, , +17

MAP17 and SGLT1 Protein Expression Levels as Prognostic Markers for Cervical Tumor Patient Survival

Marco Pérez, Juan Manuel Praena‐Fernández, Blanca Felipe‐Abrio et al. · PLoS ONE · 2013 · 57 citations · Full text

, , +16

1–5 of 17